WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here

Search

Track Your Article

Abstract

PHARMACEUTICAL STUDY OF DADIMADYA GHRITA

Amit Kumar Meena*, Amit Kumar Sharma, Sakhitha K. S. and Amit Mishra

ABSTRACT

Diabetes mellitus (DM) is a clinical syndrome characterised by hyperglycaemia due to absolute or relative deficiency of insulin. Several distinct types of Diabetes Mellitus are caused by a complex interaction of genetics and environmental factors. Ayurveda has a great potential in treating diabetes and its associated complications. Among the wide varieties of drugs mentioned in Ayurveda text books Dadimadya Ghrita has been chosen for the study so as to develop standard operating procedure for the same which help in reestablishing its efficacy and inturn contribute. Which may contribute to the successful treatment of Madhumeha (DM). The formulation of Didimadya ghrita for present study has been taken from Bhaishajya ratnavali written by Govind Das Sen in Prameha rogadhikara. Standardization technique help in monitoring the safety and efficacy of the product. However Ayurveda text books have described the quality control procedures for the raw material. In the present study Dadimadya ghritawas prepared as per classical reference to develop SOP (Standard Operating Procedure).

Keywords: Diabetes mellitus, Dadimadya Ghrita, Madhumeha, Bhaishajya ratnavali, Prameha.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More